PharmEng Reports Reduced Cash Burn, Financing Update, Strategic … - MarketWatch
|
PharmEng Reports Reduced Cash Burn, Financing Update, Strategic …
MarketWatch - As a result of the significant capacity added through the Arnprior facility acquisition, new manufacturing volumes will now be allocated between two … |
More: continued here
Permalink for PharmEng Reports Reduced Cash Burn, Financing Update, Strategic … - MarketWatch